Relationship between the degree of glycemic control and diabetes characteristics and hyperglycemia treatment in type 2 diabetes. DIABES Study;Relación del grado de control glucémico con las características de la diabetes y el tratamiento de la hiperglucemia en la diabetes tipo 2. Estudio DIABES

Medicina Clinica

Volumn 138, Issue 12, 2012, Pages 505-511

  Pérez, Antonio ^a,b   Franch, Josep ^c   Cases, Aleix ^d   González Juanatey, José Ramón ^e   Conthe, Pedro ^f   Gimeno, Eva ^g   Matali, Arantxa ^h  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Centro de Atención Primaria Raval Nord   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g Biometría Clínica S L   (Spain)

^h Almirall SA ^*  (Spain)

Author keywords

Evolution time; Glycemic control; Insulin; Oral hypoglycemic agents; Primary care; Specialty care; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE COURSE; DISEASE DURATION; GENERAL PRACTITIONER; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; METABOLIC SYNDROME X; MONOTHERAPY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; POLYPHARMACY; PRIMARY MEDICAL CARE; SPAIN; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; METFORMIN; MIDDLE AGED; MULTIVARIATE ANALYSIS; SPAIN; SULFONYLUREA COMPOUNDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84859896782     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2011.06.026     Document Type: Article

References (36)

1. L. Rydén, E. Standl, M. Bartnik, G. van den Berghe, J. Betteridge, and M.J. de Boer Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur Heart J 28 2007 88 136 (Pubitemid 46137814)
2. P. Benito, R. García, M. Puig, J. Mesa, L.F. Pallardo, and E. Faure Perfil de los pacientes con diabetes mellitus tipo 2 en atención primaria española Rev Clin Esp 204 2004 18 24
3. S. Valdés, G. Rojo-Martínez, and F. Soriguer Evolución de la prevalencia de diabetes tipo 2 en la población adulta española Med Clin (Barc) 129 2007 352 355 (Pubitemid 47581560)
4. C. López-Tinoco, J. Vergara-Chozas, and M. Aguilar-Diosdado Parámetros analíticos en el paciente con diabetes mellitus Endocrinol Nutr 53 2006 418 426 (Pubitemid 44204747)
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 329:1993;977-86.
6. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
7. M. Shichiri, H. Kishikawa, Y. Ohkubo, and N. Wake Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients Diabetes Care 23 Suppl 2 2000 B21 B29
8. A. Patel, S. MacMahon, J. Chalmers, B. Neal, L. Billot, M. Woodward ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572 (Pubitemid 351831357)
9. D.M. Nathan, P.A. Cleary, J.Y. Backlund, S.M. Genuth, J.M. Lachin, T.J. Orchard Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2005 2643 2653 (Pubitemid 41817713)
10. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577 1589
11. American Diabetes Association Standards of medical care in diabetes - 2011 Diabetes Care 34 Suppl 1 2011 S11 S61
12. J. Franch Nadal, S. Artola Menéndez, J. Diez Espino, M. Mata Cases en representación de la Red de Grupos de Estudio de la Diabetes en Atención Primaria de la Salud Evolución de los indicadores de calidad asistencial al diabético tipo 2 en Atención Primaria (1996-2007): Programa de mejora continua de calidad de la Red de Grupos de Estudio de la Diabetes en Atención Primaria de la Salud Med Clin (Barc) 135 2010 600 607
13. M.I. Harris, K.M. Flegal, R.C. Eastman, M.S. Eberhardt, and C.C. Cowie Racial and ethnic differences in glycemic control of adults with type 2 diabetes Diabetes Care 22 1999 403 408 (Pubitemid 29106894)
14. D. Orozco-Beltrán, V.F. Gil-Guillen, F. Quirce, J. Navarro-Perez, M. Pineda, A. Gomez-de-la-Cámara Collaborative Diabetes Study Investigators Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain Int J Clin Pract 61 2007 909 915 (Pubitemid 46745231)
15. M. Khattab, Y.S. Khader, A. Al-Khawaldeh, and K. Ajlouni Factors associated with poor glycemic control among patients with type 2 diabetes JDiabetes Complications 24 2010 84 89
16. T.M. Wallace, and D.R. Matthews Poor glycaemic control in type 2 diabetes, conspiracy of disease, suboptimal therapy and attitude QJM 93 2000 369 374 (Pubitemid 30386809)
17. M.K. Rhee, W. Slocum, D.C. Ziemer, S.D. Culler, C.B. Cook, and I.M. El-Kebbi Patient adherence improves glycemic control Diabetes Educ 31 2005 240 250 (Pubitemid 40529013)
18. E.P. Davila, H. Florez, M.J. Trepka, L.E. Fleming, T. Niyonsenga, and D.J. Lee Long work hours is associated with suboptimal glycemic control among US workers with diabetes Am J Ind Med 54 2011 375 383 10.1002/ajim.20923
19. E. Huppertz, L. Pieper, J. Klotsche, E. Stridde, D. Pittrow, and S. Böhler Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT Study Exp Clin Endocrinol Diabetes 117 2009 6 14
20. G. Goderis, L. Borgermans, J. Heyrman, C.V. Broeke, R. Grol, and B. Boland Type 2 diabetes in primary care in Belgium: need for structured shared care Exp Clin Endocrinol Diabetes 117 2009 367 372
21. T.J. Hoerger, J.E. Segel, E.W. Gregg, and J.B. Saaddine Is glycemic control improving in U.S. adults? Diabetes Care 31 2008 81 86
22. R.J. MacIsaac, G. Jerums, A.J. Weekes, and M.C. Thomas Patterns of glycaemic control in Australian primary care (NEFRON 8) Intern Med J 39 2009 512 518
23. S.R. Benoit, R. Fleming, A. Philis-Tsimikas, and M. Ji Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study BMC Public Health 5 2005 36
24. S.J. Spann, P.A. Nutting, J.M. Galliher, K.A. Peterson, V.N. Pavlik, and L.M. Dickinson Management of type 2 diabetes in the primary care setting: a practice-based research network study Ann Fam Med 4 2006 23 31 (Pubitemid 43243909)
25. H.C. Gerstein, M.E. Miller, R.P. Byington, D.C. Goff Jr, J.T. Bigger, J.B. Buse for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Group Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559 (Pubitemid 351831356)
26. W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele, P.D. Reaven for the VADT Investigators Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139
27. K.J. Blumenthal, M.E. Larkin, G. Winning, D.M. Nathan, and R.W. Grant Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study BMC Health Serv Res 10 2010 158
28. L.N. McEwen, D. Bilik, S.L. Johnson, J.B. Halter, A.J. Karter, and C.M. Mangione Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD) Diabetes Care 32 2009 971 976
29. E. Menéndez Torre, F.J. Lafita Tejedor, S. Artola Menéndez, S. Millán Núñez-Cortés, A. Alonso García, and M. Puig Domingo Recomendaciones para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2 Av Diabetol 26 2010 331 338
30. L.S. Phillips, W.T. Branco, C.B. Cook, J.P. Doyle, I.M. El-Kebbi, and D.L. Gallina Clinical inertia Ann Intern Med 135 2001 825 834 (Pubitemid 33051266)
31. J.B. Brown, G.A. Nicholas, and A. Perry The burden of treatment failure in type 2 diabetes Diabetes Care 27 2004 1535 1540 (Pubitemid 38857422)
32. S.B. Harris, J. Kapor, C.N. Lank, A.R. Willan, and T. Houston Clinical inertia in patients with T2DM requiring insulin in family practice Can Fam Physician 56 2010 e418 e424
33. J.S. Skyler, R. Bergenstal, R.O. Bonow, J. Buse, P. Deedwania, E.A. Gale American Diabetes Association, American College of Cardiology Foundation, American Heart Association Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association Diabetes Care 32 2009 187 192
34. F. Ismail-Beigi, E. Moghissi, M. Tiktin, I. Hirsch, S. Inzucchi, and S. Genuth Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials Ann Intern Med 154 2011 554 559
35. M.J. Blaha, T. Gebretsadik, A. Shintani, and T.A. Elasy Waist circumference, not the metabolic syndrome, predicts glucose deterioration in type 2 diabetes Obesity (Silver Spring) 16 2008 869 874 (Pubitemid 351465645)
36. L.M. Thorn, C. Forsblom, J. Fagerudd, M.C. Thomas, K. Pettersson-Fernholm, M. Saraheimo FinnDiane Study Group Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study) Diabetes Care 28 2005 2019 2024 (Pubitemid 41060978)